ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EVG Evgen Pharma Plc

0.80
0.00 (0.00%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 422k -4.04M -0.0147 -0.51 2.06M
Evgen Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 0.80p. Over the last year, Evgen Pharma shares have traded in a share price range of 0.75p to 3.95p.

Evgen Pharma currently has 274,888,117 shares in issue. The market capitalisation of Evgen Pharma is £2.06 million. Evgen Pharma has a price to earnings ratio (PE ratio) of -0.51.

Evgen Pharma Share Discussion Threads

Showing 12426 to 12450 of 13025 messages
Chat Pages: Latest  509  508  507  506  505  504  503  502  501  500  499  498  Older
DateSubjectAuthorDiscuss
10/11/2023
11:26
Given the sale price I'm being offered all of todays 264k are buys. Someone getting bargains but I can't possibly add more as much as I'd like to
markth126
07/11/2023
16:15
OT I agree better to buy £500 worth of stock at this price, as someone seems to have done today.
clocktower
07/11/2023
16:01
I certainly won't be giving £500 to some website I've never heard of, to tell me nothing that isn't already in the public domain.
on target
07/11/2023
15:57
An educated opinion on the future potential is not something EVG could comment on at this time. The results that everyone expects should answer that question but until then one can only listen to experts in the field as to the chances of success.

However, there has been a canny buyer that picks up stock as the price slides - in fact the last sell of around 400k the other week - half was quickly taken up but they leave some on the table in hope of picking up more at this sort of level it seems to me.

clocktower
07/11/2023
15:45
Would they publish anything of market relevance without EVG reporting it at the same time? I think not
markth126
07/11/2023
15:18
If it makes good reading then I thought it would be valuable to anyone with a big holding but then if it's not I guess it would only be upsetting. However,would they publish and charge £500.00 to deliver bad news - I think not. 😊
clocktower
07/11/2023
13:12
Not sure what the report says about the outcome expectation as it's £500 .
markth126
07/11/2023
08:00
I notice breast cancer prevention drugs are all over the papers again today, unfortunately not this one yet. Still it may attract interest I guess.
clocktower
06/11/2023
08:58
I think you'll start to see steady buying when it gets to 1.4p
paulhudd
02/11/2023
16:55
Crickey, Alf we'd be in a sorry state of every CEO had to justify their share price performance in this market. Most MedTech stocks have been hammered
hatfullofsky
02/11/2023
13:03
Well the market is clearly seeing through all the bods Bullsxxt, such optimism but that doesn't stretch to them buying in. Please don't invest on what the new CFO was saying about adding to shareholder value, this lot are only in it for themselves. I would have expected them to at least acknowledge the dire share price performance over the last 9 months, but no it was the usual promising the earth drivel to entice more unsuspecting punters. Aim company and board at its worst.
kingalf
02/11/2023
11:27
Back where we were with that sell of almost 400k and I am not sure about them being swept up in the current climate W.
clocktower
02/11/2023
10:07
I think that volume sell just a Bored PI. Will be swept up later
wololol
02/11/2023
09:28
I was thinking exactly the same Wololol, finger crossed
hatfullofsky
02/11/2023
09:05
Nice and quiet here on the western front. Looks like global markets and AXX share may have bottomed as interest rates freeze and should fall start of next year. Selling has dried up here so any buys should push it upwards.
wololol
31/10/2023
19:37
Any phase 3 is no guarantee of success look at POLX
hatfullofsky
31/10/2023
19:35
Any investment in a £5m, pre-revenue, Phase 1 company is a gamble. But you have to be in it to win it, so many like myself an Knight will have a basket of moon shots, it only takes one to pay for the others and some
hatfullofsky
31/10/2023
18:14
Gambler or not, one thing is for certain, he must regret the day Evgen first came to his attention. Massive paper loss, will he throw in the towel so as to offset it against tax. That would keep a lid on any rise.
kingalf
31/10/2023
13:50
Right now I would take 2.5p which is more than I paid for the small number I bought back after selling at circa 2.5p and taking a hefty loss.
clocktower
31/10/2023
13:43
All premature talk of buyouts etc. 8p is not what I've been here for the last 3 years for.
markth126
31/10/2023
13:15
The question is what would shareholders accept. I'd take 8p so 4x where we are now that's reasonable, although some would argue it's worth a lot more.
wololol
31/10/2023
12:57
hat - I am sure they have an insight to the potential by now, and before they make any further milestone payments it might well be in their best interest to make an offer that might be accepted by most stakeholders at this point in time, to save themselves a huge amount and likely benefit from other research that is being carried out.

While we are gamblers, those that have deep knowledge in the pharma field, invest for what they truly believe will be long term benefits not only to patients but to themselves as well.

Your not going to tell me that the likes of J R Kight whom holds 12% is a gambler.

clocktower
31/10/2023
11:48
Stalicia would be crazy TO buy the company now with only phase 1/1b complete. They're not gamblers like us.
hatfullofsky
31/10/2023
07:58
A takeover below 20 million quid would be of no interest to me. If it works, presumably the key shareholders would want considerably more than that anyway, and if it does not, 20 million would be a pipedream anyway.
Mark: I am sorry to say that I simply do not believe that the window to buy shares here has been closed all this time.
But I remain here for those results, in spite of the BOD. GLA.

lovewinshatelosses
31/10/2023
07:51
Yes a takeover is likely hence why building a position at low levels. Lots of AIM companies being snapped up at the moment. Lots of news flow due in the next couple of months also. If the drug successfully manipulates the gene mRNA from their findings as intended then the share price will go ballistic. Not long to find out as well.
wololol
Chat Pages: Latest  509  508  507  506  505  504  503  502  501  500  499  498  Older

Your Recent History

Delayed Upgrade Clock